If you're considering a biosimilar medication, there are a few key questions to ask yourself. First and foremost, consider the impact on cost, as biosimilars have been shown to reduce out-of-pocket expenses by up to 45% in some cases. Next, review the data and make sure that you feel comfortable with the regulatory process and the evidence of biosimilarity. At the end of the day, it's important to choose a medication that will provide the same safety and efficacy as the reference product while also reducing costs for the patient. #biosimilars #patientcare #medicationoptions #costeffectiveness
Tim de Gavre is vice president and chief commercial officer, Sandoz.
Link in bio or visit kevinmd.com/podcast
SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast
RATE AND REVIEW → https://www.kevinmd.com/rate
FOLLOW ON INSTAGRAM → https://www.instagram.com/kevinphomd
FOLLOW ON TIKTOK → https://www.tiktok.com/@kevinphomd
